From 1996 to 2004, she served as assistant professor of psychiatry at the University of Massachusetts.[2][3] From 2009 to 2012, she served as medical director for behavioral health at Capital District Physician's Health Plan.[3][5] She was a founding faculty member of the Virginia TechCarilion School of Medicine in 2010, where she taught until 2016.[1][3]
From 2012 to 2014, she served as chief medical officer of Behavioral Health Group.[3][6] From 2014 to 2015, she was Chief Medical Officer of CleanSlate Centers[3][7][8] and from 2014 to 2018, she was medical director of CVS Caremark.[3][8][9] In 2018, she founded and became President of Addiction Crisis Solutions,[10][11][12][3] and she also joined the board of drug disposal company DisposeRX.[13][3]
She was vice-chair of ASAM's COVID-19 Task Force.[2]
Research and advocacy
Clark's areas of focus are addictive disease, behavioral health care, and health care payment reform.[1][10][11] She has advocated the use of FDA-approved drugs to treat drug and alcohol addiction as a chronic brain disease.[15][16] However, she acknowledges that there are challenges patients face in obtaining access to methadone, naltrexone, and buprenorphine, the three FDA-approved medications for treating opioid addiction.[17]
She has helped develop guidelines for dealing with opioid addiction in the workplace,[18] medication-assisted treatment for opioid addiction,[19][20] and drug testing.[21]
Clark, Kelly J.; et al. (November 2015). Alexander, G. Caleb; Frattaroli, Shannon; Gielen, Andrea C. (eds.). The prescription opioid epidemic: an evidence-based approach (PDF) (Report). Johns Hopkins Bloomberg School of Public Health.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
